Sarah Roden

About the Author Sarah Roden

Sarah writes about stock market news for TipRanks. She graduated as member of Phi Beta Kappa from the University of Richmond in Richmond, Virginia.

Cantor Sets Expectations on Facebook Inc (FB) and Amazon.com, Inc. (AMZN) Ahead of Earnings

As internet giants prepare to post earnings this week, Youssef Squali of Cantor weighs in on Facebook Inc (NASDAQ:FB) and Amazon.com, Inc.

Equity Insights: Twitter Inc (TWTR), Ctrip.com International, Ltd. (ADR) (CTRP)

Analysts weigh in on micro-blogging giant Twitter Inc (NYSE:TWTR) as the company prepares to post earnings tomorrow afternoon, and online travel leader Ctrip.com International, Ltd.

Wall Street’s Week Ahead: Facebook Inc (FB), Twitter Inc (TWTR), and LinkedIn Corp (LNKD)

Analysts and investors are tuning in this week for earnings from social media giants Facebook Inc (NASDAQ:FB), Twitter Inc (NYSE:TWTR), and LinkedIn Corp …

Biotech Week Ahead: Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG), Keryx Biopharmaceuticals (KERX)

Thursday is a big day for biotech as Gilead Sciences, Inc. (NASDAQ:GILD), Celgene Corporation (NASDAQ:CELG), and Keryx Biopharmaceuticals (NASDAQ:KERX) will all be posting …

Ahead of Earnings: Baird Weighs In on Alibaba Group Holding Ltd (BABA), Twitter Inc (TWTR), Amazon.com, Inc. (AMZN), Facebook Inc (FB)

Internet giants Facebook Inc (NASDAQ:FB), Alibaba Group Holding Ltd (NYSE:BABA), Twitter Inc (NYSE:TWTR), and Amazon.com, Inc.

Earnings Frenzy: Analysts Chime In on Celgene Corporation (CELG) and Illumina, Inc. (ILMN)

Analysts weigh in on healthcare stocks Celgene Corporation (NASDAQ:CELG) and Illumina, Inc. (NASDAQ:ILMN) amid the earnings frenzy.

Maxim Analysts Bullish On Pioneering Biotech Stocks: Mast Therapeutics Inc (MSTX) and StemCells Inc (STEM)

Both Mast Therapeutics Inc (NYSEMKT:MSTX) and StemCells Inc (NASDAQ:STEM) are in deep waters where few other biotech giants tread. While Mast is working …

Analysts Weigh In On Volatile Biotech Stocks: Illumina, Inc. (ILMN), Heron Therapeutics Inc (HRTX)

While Illumina, Inc. (NASDAQ:ILMN) disappointed investors by lowering revenue outlook, Heron Therapeutics Inc (NASDAQ:HRTX) started the week off strong with good news from …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts